Naveena Singh
Impact in
- Obstetrics and Gynecology top 0.05%
- Endometrial and Cervical Cancer Treatments
- Reproductive Medicine top 0.05%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Ovarian cancer diagnosis and treatment 92
-
- Endometrial and Cervical Cancer Treatments 77
- Co-authors
- C. Blake Gilks (41 shared papers)W. Glenn McCluggage (32 shared papers)Tjalling Bosse (17 shared papers)Martin Köbel (9 shared papers)C. Blake Gilks (15 shared papers)Nafisa S. Wilkinson (11 shared papers)Aldo Scarpa (1 shared paper)Frédéric Bibeau (1 shared paper)
- Journals
- International Journal of Gynecological Pathology (33 papers)Histopathology (21 papers)International Journal of Gynecological Cancer (18 papers)Cytopathology (10 papers)Clinical Cancer Research (9 papers)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Naveena Singh
208 papers receiving 11.7k citations
Naveena Singh's Hit Papers
Peers
Comparison fields: 5 of 136
- Obstetrics and Gynecology 4.0k
- Reproductive Medicine 4.5k
- Cancer Research 1.6k
- Oncology 2.2k
- Pathology and Forensic Medicine 1.2k
Countries citing papers authored by Naveena Singh
This map shows the geographic impact of Naveena Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naveena Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naveena Singh more than expected).
Fields of papers citing papers by Naveena Singh
This network shows the impact of papers produced by Naveena Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naveena Singh. The network helps show where Naveena Singh may publish in the future.
Co-authors
The 25 scholars most cited alongside Naveena Singh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 217 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach Hit paper breakdown → | 2019 | 803 |
| 2 | Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial Hit paper breakdown → | 2015 | 790 |
| 3 | Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Hit paper breakdown → | 2009 | 663 |
| 4 | Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy Hit paper breakdown → | 2020 | 588 |
| 5 | Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial Hit paper breakdown → | 2021 | 491 |
| 6 | Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial Hit paper breakdown → | 2018 | 463 |
| 7 | 2011 | 341 | |
| 8 | Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial Hit paper breakdown → | 2019 | 337 |
| 9 | 2018 | 311 | |
| 10 | 2017 | 303 | |
| 11 | 2005 | 276 | |
| 12 | 2019 | 238 | |
| 13 | 2015 | 229 | |
| 14 | 2019 | 188 | |
| 15 | 2015 | 165 | |
| 16 | 2017 | 164 | |
| 17 | 2010 | 160 | |
| 18 | 2016 | 131 | |
| 19 | 2018 | 120 | |
| 20 | 2022 | 116 |
About Naveena Singh
Naveena Singh is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Epidemiology, Cancer Research and Pathology and Forensic Medicine, having authored 217 papers that have together received 12.0k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (92 papers), Endometrial and Cervical Cancer Treatments (77 papers), Cervical Cancer and HPV Research (42 papers), Cancer Genomics and Diagnostics (18 papers), Genetic factors in colorectal cancer (16 papers), Colorectal and Anal Carcinomas (14 papers), Sarcoma Diagnosis and Treatment (9 papers) and Cancer-related molecular mechanisms research (8 papers). The work is most often cited by research in Obstetrics and Gynecology (4.0k citations), Reproductive Medicine (4.5k citations), Cancer Research (1.6k citations), Oncology (2.2k citations) and Pathology and Forensic Medicine (1.2k citations). Naveena Singh has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include C. Blake Gilks, W. Glenn McCluggage, Tjalling Bosse, Martin Köbel, C. Blake Gilks, Nafisa S. Wilkinson, Aldo Scarpa, Frédéric Bibeau, Fabrice André and Claudio Luchini. Their work appears in journals such as International Journal of Gynecological Pathology, Histopathology, International Journal of Gynecological Cancer, Cytopathology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.